{"denoms":[{"counts":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"85"},{"groupId":"BG002","value":"162"}],"units":"Participants"}],"groups":[{"description":"Observation (+/- Radiation). Patients receive radiotherapy\\* within 6 months after surgery.\n\nradiation therapy: Given within 6 months after surgery","id":"BG000","title":"Arm I"},{"description":"Chemotherapy (+/- Radiation). Within 10 weeks after surgery, patients receive at least 3 courses of an adjuvant chemotherapy regimen as determined by the investigator. Patients may receive radiotherapy within 6 months after surgery and after the completion of chemotherapy OR integrated with chemotherapy.\n\nchemotherapy: Given within 10 weeks after surgery.","id":"BG001","title":"Arm II"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"131"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"31"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"85"},{"groupId":"BG002","value":"162"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"42"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"33"}]}],"title":"Hungary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"31"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"20"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Peru"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"Australia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}]}],"title":"South Africa"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"12"}]}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"16"}]}],"title":"Switzerland"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"49"},{"groupId":"BG002","value":"101"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"61"}]}],"title":"No"}],"paramType":"NUMBER","title":"Prior chemotherapy","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"64"}]}],"title":"Mastectomy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"52"},{"groupId":"BG002","value":"98"}]}],"title":"Breast conserving"}],"paramType":"NUMBER","title":"Surgery for primary tumor","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"104"}]}],"title":"Positive"},{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"58"}]}],"title":"Negative"}],"paramType":"NUMBER","title":"Estrogen receptor (ER) status of the isolated local or regional recurrence","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"79"}]}],"title":"positive"},{"categories":[{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"79"}]}],"title":"negative"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}]}],"title":"not available"}],"paramType":"NUMBER","title":"Progesterone receptor (PgR) status of the isolated local or regional recurrence","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"88"}]}],"title":"Breast"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"53"}]}],"title":"Mx scar/chest wall"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"21"}]}],"title":"Regional lymph nodes"}],"paramType":"NUMBER","title":"Location of isolated loco-regional recurrence (ILRR)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"34"}]}],"title":"pre"},{"categories":[{"measurements":[{"groupId":"BG000","value":"63"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"128"}]}],"title":"post"}],"paramType":"NUMBER","title":"Menopausal Status at isolated loco-regional recurrence (ILRR)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"2.9","upperLimit":"11.3","value":"6.2"},{"groupId":"BG001","lowerLimit":"2.9","upperLimit":"9.5","value":"5.0"},{"groupId":"BG002","lowerLimit":"2.9","upperLimit":"11.3","value":"5.5"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Time from primary surgery to isolated loco-regional recurrence (ILRR) surgery","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"47"}]}],"title":"negative"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"49"},{"groupId":"BG002","value":"96"}]}],"title":"positive"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"19"}]}],"title":"unknown"}],"paramType":"NUMBER","title":"Estrogen receptor (ER) status of primary tumor","unitOfMeasure":"participants"}]}